News Feed Comments

Court rebuffs Actavis on Vyvanse – FiercePharma

Court rebuffs Actavis on Vyvanse
FiercePharma
A US district court judge in DC has upheld an FDA decision to grant five years of market exclusivity to Shire's ADHD drug Vyvanse (lisdexamfetamine), ...
Shire: District Court Upholds FDAs Grant of 5-Year Exclusivity Wall Street Journal

Actavis Loses to FDA in ADHD Drug Ruling Courthouse News Service
Shire given market exclusivity for ADHD drug Drug Store News (blog)
FOXBusiness - Pharma Times
all 36 news articles »

Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Actavis, Adhd, Courthouse News, District Court Judge, Drug Store News, Fda, Fda Decision, Lisdexamfetamine, Market Exclusivity, News Articles, News Service, Us District Court, Vyvanse, Wall Street, Wall Street Journal

Footer #1 Widget

This is an example of a widgeted area that you can place text to describe a particular product or service.
You can also use other WordPress widgets such as recent posts, recent comments, tag clouds, etc.

Footer #2 Widget

This is an example of a widgeted area that you can place text to describe a particular product or service.
You can also use other WordPress widgets such as recent posts, recent comments, tag clouds, etc.

Footer #3 Widget

This is an example of a widgeted area that you can place text to describe a particular product or service.
You can also use other WordPress widgets such as recent posts, recent comments, tag clouds, etc.

Footer #4 Widget

This is an example of a widgeted area that you can place text to describe a particular product or service.
You can also use other WordPress widgets such as recent posts, recent comments, tag clouds, etc.

© 2010 VyvanseInfo.com · Streamline theme by StudioPress · Get a Blog · WordPress · Log in